Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism

Mol Nutr Food Res. 2021 Jan;65(1):e1900580. doi: 10.1002/mnfr.201900580. Epub 2020 Jun 21.

Abstract

Scope: Dietary fiber (DF) induces changes in gut microbiota function and thus modulates the gut environment. How this modulation is associated with metabolic pathways related to the gut is largely unclear. This study aims to investigate differences in metabolites produced by the gut microbiota and their interactions with host metabolism in response to supplementation with two bran fibers.

Methods and results: Male C57BL/6N mice are fed a western diet (WD) for 17 weeks. Two groups of mice received a diet enriched with 10% w/w of either oat or rye bran, with each bran containing 50% DF. Microbial metabolites are assessed by measuring cecal short-chain fatty acids (SCFAs), ileal and fecal bile acids (BAs), and the expression of genes related to tryptophan (TRP) metabolism. Both brans lowered body weight gain and ameliorated WD-induced impaired glucose responses, hepatic inflammation, liver enzymes, and gut integrity markers associated with SCFA production, altered BA metabolism, and TRP diversion from the serotonin synthesis pathway to microbial indole production.

Conclusions: Both brans develop a favorable environment in the gut by altering the composition of microbes and modulating produced metabolites. Changes induced in the gut environment by a fiber-enriched diet may explain the amelioration of metabolic disturbances related to WD.

Keywords: dietary fiber; gut metabolism; microbial metabolites; obesity; prebiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Avena / chemistry
  • Bile Acids and Salts / metabolism*
  • Body Composition / drug effects
  • Diet, Western / adverse effects*
  • Dietary Fiber / pharmacology*
  • Fatty Acids, Volatile / metabolism*
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / physiology
  • Glucose / metabolism
  • Hepatitis / diet therapy*
  • Hepatitis / etiology
  • Hepatitis / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / diet therapy
  • Non-alcoholic Fatty Liver Disease / etiology
  • Secale / chemistry
  • Tryptophan / metabolism
  • Weight Gain / drug effects

Substances

  • Bile Acids and Salts
  • Dietary Fiber
  • Fatty Acids, Volatile
  • Tryptophan
  • Glucose